Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Mason

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology|September 6, 2011
Socio-economic inequalities in testicular cancer survival within two clinical studiesUla Nur, Bernard Rachet, Mahesh K B Parmar, et al.
European Urology|December 11, 2013
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerAxel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
European Urology|November 9, 2010
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised diseaseAxel Heidenreich, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|February 15, 2011
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|November 12, 2013
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2019
Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapySarah Wilding, Amy Downing, Penny Wright, et al.
Plos One|September 26, 2018
Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?Peter C Elwood, Janet E Pickering, Gareth Morgan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancerNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancerJohann Sebastian de Bono, Joaquim Bellmunt, Gerhardt Attard, et al.
European Urology|June 9, 2012
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancerJoshua J Meeks, Joaquim Bellmunt, Bernard H Bochner, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology|September 6, 2011
Socio-economic inequalities in testicular cancer survival within two clinical studiesUla Nur, Bernard Rachet, Mahesh K B Parmar, et al.
European Urology|December 11, 2013
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerAxel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
European Urology|November 9, 2010
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised diseaseAxel Heidenreich, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|February 15, 2011
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|November 12, 2013
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2019
Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapySarah Wilding, Amy Downing, Penny Wright, et al.
Plos One|September 26, 2018
Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?Peter C Elwood, Janet E Pickering, Gareth Morgan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancerNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancerJohann Sebastian de Bono, Joaquim Bellmunt, Gerhardt Attard, et al.
European Urology|June 9, 2012
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancerJoshua J Meeks, Joaquim Bellmunt, Bernard H Bochner, et al.
Pageof 8